FDA Investigator Lisa Hayka

Lisa Hayka has conducted inspections on 179 sites in 4 countries as of 28 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
179
Last Inspection Date:
28 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
100004799
Countries of Inspections:
United States of America, Germany, Belgium, France
FDA Investigators that have inspected at least one site in common with Lisa Hayka:
Adam J Taylor, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana L Kewes, Andrew A Leboeuf, Andria L Kuhlman, Ashley L Reiber, Azza Talaat, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Bryce H Thompson, Carl A Huffman, III, Carlyn L Ray, Carrie Ann Plucinski, Chad E Schmear, Charles A Snipes, PhD, Charlie P Booker, Chrissy J Cochran, Christina A Miller, Christopher D Leach, Clotia Cabbey Mensah, Colleen E Burke, Connie R Kiessling, Dariusz Galezowski, Darrell E Luedtke, David J Gasparovich, David K Glasgow, David Perkins, Debra I Love, Debra Lboyd Seale, Denarvis C Mendenhall, Denise L Burosh, Dr. Mark J Seaton, PhD, Edwin Melendez, Emest F Bizjak, Emma R Schaefer, Eric M Mueller, PharmD, Eric S Pittman, Eric T Huebler, Erin M Mcdowell, Esther A Ofori, Gregory R Dill, Humera T Khan, James E Roberts, James P Duggan, James W Plucinski, Janae D Price, Janete F Guardia, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Adams, Jennifer C Johnson, Jeremy W Rotton, Jesse A Vazquez, Jocelyn E Massey, Joey V Quitania, John E Verbeten, John M Seale, Jonee J Mearns, Jose Acruz Gonzalez, Joseph A Morkunas, Joseph D Cooper, Joshua M Adams, Karen Emasley Joseph, Kathleen A Schelble, Kathleen S Tormey, Kendra A Biddick, Kujtim Sadiku, Lana K Waselewski, Larry F Hallberg, Lauren A Crivellone, Laurie A Haxel, Laurimer Kuilan Torres, Lee Terry Moore, Lequita M Mayhew, Libia M Lugo, Linda R Kuchenthal, Lisa Hornback, Marcia A Worley, Margaret Torres Vazquez, Margarita Santiago, Maria Diaz, Mark G Peterson, Mark I Kaspar, Martin K Yau, PhD, Matthew B Casale, Matthew J Gretkierewicz, Matthew J Sienko, Matthew R Buenconsejo, Michael D Robinson, Michele L Forster, PhD, Michelle L Dragon Nagel, Miguel A Martinez Perez, Nadeem I Chaudhry, Natasha R Johnson, Nicholas F Lyons, Nicholas P Diorio, Nicole C Victoria, PhD, Nicole J Clausen, Nicole S Williams, Norman K Starks, Norman L Brown, Norman Wong, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Paul L Figarole, Jr, Peng Zhou, Phung Thien Nguyen, Rachel E Mcguigan, Rafael E Arroyo, Rafael Padilla, Rebecca Rodriguez, Rita K Kabaso, Robert D Tollefsen, Robert J Ham, Roberta W Cunningham, Rosemary Wood Sexton, Roshni J Patel, Russell K Riley, Samuel T Walker, Sarah L Roman, Sarah Nwandiuko, Scott B Laufenberg, Shalonda C Clifford, Shana L Williams, Shannon A Dinardo, Sneha S Patel, Stefen D Mcmillan, Stephen D Eich, Steven A Gonzales, Sullan, Susan D Yuscius, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tamara M Qtami, Tara C Alcazar, Tara M Carolfi, That Q Dang, Thomas J Arista, Thunder N Dunkijacobs, Todd M Stankewicz, Todd Q Dang, Tong Zhou, Uruaku A Obasi, Veronica Fuentes, MS, William D Sherman, William G Nelson, William R Weissinger, Xiaokuang Lai, PhD, Yuanyuan Li, Yvonne E Lozano, Zachary L Miller

Lisa Hayka's Documents

Publish Date Document Type Title
July, 2001 EIR Markey, William S., M.D. - EIR, 2001-07-25
December, 2000 EIR Thermo-Pak Co - EIR, 2000-12-12
October, 2022 FDA 483 Randy J. Epstein, M.D. - Form 483, 2022-10-26
September, 2004 FDA 483 Patrick J. Stiff, M.D. - Form 483, 2004-09-10
October, 2002 FDA 483 PolyPeptide SA - Form 483, 2002-10-07
September, 2003 FDA 483 Meda Pharmaceuticals Inc. - Form 483, 2003-09-19
October, 2002 EIR Janssen Pharmaceutica NV - EIR, 2002-10-03
February, 2000 FDA 483 IIT Research Institute - Form 483, 2000-02-18
April, 2002 EIR Abbott Laboratories - EIR, 2002-04-03
December, 2005 EIR Rush University Medical Center IRB - EIR, 2005-12-21
April, 2002 FDA 483 Abbott Laboratories - Form 483, 2002-04-03
May, 2000 EIR Kuzel, Timothy M., M.D. - EIR, 2000-05-18
April, 2002 FDA 483 Response Abbott Laboratories - Form 483R, 2002-04-18
May, 2000 FDA 483 Northwestern Memorial Hospital, Clinical Research Office - Form 483, 2000-05-18
April, 2009 FDA 483 Greenbaum, Michael S., M.D. - Form 483, 2009-04-17
February, 2009 FDA 483 Danny H. Sugimoto, M.D. - Form 483, 2009-02-23
January, 2009 FDA 483 Response Geohas, Jeffrey G., MD - Form 483R, 2009-01-22
March, 2001 FDA 483 G.D. Searle & Co. - Form 483, 2001-03-22
March, 2008 FDA 483 Experimur, A Frontage Company - Form 483, 2008-03-13
October, 2002 EIR PolyPeptide SA - EIR, 2002-10-07
September, 2003 EIR Meda Pharmaceuticals Inc. - EIR, 2003-09-19
February, 2009 EIR Northwest Comm Hospital IRB - EIR, 2009-02-18
May, 2004 FDA 483 Abbott Laboratories - Form 483, 2004-05-28
July, 2001 FDA 483 Response Markey, William S., M.D. - Form 483R, 2001-07-26
February, 2003 FDA 483 Illinois Retina Associates, SC, Pauline T. Merrill, M.D., CI - Form 483, 2003-02-04
October, 2002 FDA 483 Response PolyPeptide SA - Form 483R, 2002-10-29
September, 2000 EIR Davidson, Michael H., M.D. - EIR, 2000-09-15
August, 2008 EIR Northwestern University IRB - EIR, 2008-08-08
March, 2000 EIR Freitag, Frederick G. - EIR, 2000-03-17
May, 2003 EIR PreLabs, LLC - EIR, 2003-05-13
October, 2002 FDA 483 Janssen Pharmaceutica NV - Form 483, 2002-10-03
March, 2001 EIR E. Merck - EIR, 2001-05-16
October, 2021 EIR Veeral S. Sheth, M.D. - EIR, 2021-10-08
April, 2004 FDA 483 Midwest Heart Foundation - Form 483, 2004-04-09
May, 2003 FDA 483 Response PreLabs, LLC - Form 483R, 2003-06-02
August, 2000 FDA 483 Midwest Center for Neurobehavioral Medicine - Form 483, 2000-08-31
September, 2000 FDA 483 Chicago Center for Clinical Research - Form 483, 2000-09-15
April, 2005 EIR Takeda Global Research & Development - EIR, 2005-04-27
July, 2001 FDA 483 ICCT, William S. Markey, M.D. - Form 483, 2001-07-25
February, 2009 FDA 483 Northwest Comm Hospital IRB - Form 483, 2009-02-18
October, 2002 FDA 483 Response Janssen Pharmaceutica NV - Form 483R, 2002-10-18
February, 2009 EIR Danny H. Sugimoto, M.D. - EIR, 2009-02-23
August, 2000 EIR Fanelli, Joseph G., M.D. - EIR, 2000-08-31
March, 2000 FDA 483 Freitag, Frederick G. - Form 483, 2000-03-17
March, 2001 FDA 483 Response E. Merck - Form 483R, 2001-04-12
February, 2000 EIR IIT Research Institute - EIR, 2000-02-18
December, 2005 FDA 483 Rush University Medical Center IRB - Form 483, 2005-12-21
January, 2009 FDA 483 Geohas, Jeffrey G., MD - Form 483, 2009-01-13
December, 2004 FDA 483 Wilber, David J., M.D. - Form 483, 2004-12-17
April, 2009 EIR Greenbaum, Michael S., M.D. - EIR, 2009-04-17
February, 2009 FDA 483 Response Danny H. Sugimoto, M.D. - Form 483R, 2009-02-27
March, 2001 EIR G.D. Searle & Co. - EIR, 2001-03-22
January, 2001 EIR Pfanstiehl Inc - EIR, 2001-01-19
January, 2009 EIR Geohas, Jeffrey G., MD - EIR, 2009-01-13
August, 2000 FDA 483 Response Fanelli, Joseph G., M.D. - Form 483R, 2000-09-26
December, 2000 FDA 483 Thermo-Pak Co - Form 483, 2000-12-12
November, 2000 EIR Reinstein, Michael J., M.D. - EIR, 2000-11-20
November, 2000 FDA 483 Forest Foundation, Inc., Michael J. Reinstein, M.D. - Form 483, 2000-11-20
January, 2001 FDA 483 Pfanstiehl Inc - Form 483, 2001-01-19
May, 2003 FDA 483 PreLabs, LLC - Form 483, 2003-05-13
December, 2000 FDA 483 Response Thermo-Pak Co - Form 483R, 2001-02-06
April, 2009 FDA 483 Response Greenbaum, Michael S., M.D. - Form 483R, 2009-04-27
July, 2003 FDA 483 Omron Healthcare, Inc. - Form 483, 2003-07-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more